SCHEMBL12484653

SCHEMBL12484653

CC(C)(CNC(=O)c1csc(CNC(=O)COc2ccc(O)cc2)n1)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.44
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
POLB P06746 1/20 0.40
MAPT P10636 3/20 0.40
GAA P10253 1/20 0.40
HTT P42858 1/20 0.40
HPGD P15428 1/20 0.39
KMT2A Q03164 1/20 0.39
GALR3 O60755 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13787358 0.90 SMN1; SMN2 (0.42) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL12481961 0.79 HTT (0.46) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4387696 0.76 MAPT (0.61) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL5667982 0.74 KDM4E (0.47) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4392406 0.73 ALDH1A1 (0.43) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4395355 0.73 ALDH1A1 (0.43) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4383724 0.73 ALDH1A1 (0.43) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL5669968 0.73 CYP1A2 (0.41) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL5667985 0.72 MAPT (0.54) SMN1; SMN2POLBMAPTHPGDKMT2A
SCHEMBL4383973 0.72 EPHX2 (0.45) SMN1; SMN2CYP1A2CYP2C19MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7973061-B2 Anaplastic lymphoma kinase modulators and methods of use EXELIXIS, INC. (US) 2011-07-05 US disclosed